Associated Papers
RHD genotyping to resolve weak and discrepant RhD patient phenotypes.
Barriteau CM et al.
Transfusion, 2022
Performance evaluation of differential splicing analysis methods and splicing analytics platform construction.
Li K et al.
Nucleic Acids Research, 2022
35993808 (PubMed )
Supplement: gkac686_supplemental_files.zip › Table_S4_The_positive_and_negative_splicing_variants_benchmarker.xlsx › ROC
Impact of RHD genotyping on transfusion practice in Denmark and the United States and identification of novel RHD alleles.
Vege S et al.
Transfusion, 2021
Functional analysis of novel RHD variants: splicing disruption is likely to be a common mechanism of variant D phenotype.
Raud L et al.
Transfusion, 2019
Corrigendum: Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effort.
Leman R et al.
Nucleic Acids Research, 2018
30321405 (PubMed )
Supplement: gky979_supplemental_files.zip › Corrigendum_supplementary_table.xlsx › AllData
Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effort.
Leman R et al.
Nucleic Acids Research, 2018
29750258 (PubMed )
Supplement: gky372_supplemental_files.zip › SPiCE_table_supp.R2.xlsx › Table_S3
Extensive functional analyses of RHD splice site variants: Insights into the potential role of splicing in the physiology of Rh.
Fichou Y et al.
Transfusion, 2015
RHD and RHCE variant and zygosity genotyping via multiplex ligation-dependent probe amplification.
Haer-Wigman L et al.
Transfusion, 2013
DIII Type 7 is likely the original serologically defined DIIIb.
Lomas-Francis C et al.
Transfusion, 2012
Select a paper to view details